Care Optimisation

Interface Clinical Services (ICS) deliver bespoke care optimisation services to the NHS that support healthcare professionals to enhance the way that care is provided to their patients.

Our clinical pharmacist team can also work directly with patients, be it face-to-face or providing support remotely, to ensure they are informed and engaged in their treatment programme. This encourages patients to increase their commitment and work with clinicians to optimise their own care and wellbeing.

Care Optimisation

Care Optimisation

Our experienced pharmacist team partner with practices, using their experience, expertise and in-depth clinical knowledge to suggest a range of interventions that are tailored to the patient’s individual needs, with easy-to-measure outcomes and key performance indicators.

Many clinicians are caring for multiple patients with several co-morbidities, ICS can focus on individual conditions and therapy areas to optimise treatment whilst enhancing the patients overall care and improving outcomes. Optimising care in this way not only improves the patients’ experience, it can improve their overall quality of life by streamlining treatments in an effective and efficient manner.

ICS pharmacists can deliver recommended interventions, or alternatively we can support practice teams to deliver an internal care optimisation project. This includes facilitating ongoing education and support to patients, in line with local guideline and initiatives, which encourages adherence and the correct use of medicines and devices.

Case Study

Optimising Treatment in Osteoporosis

Osteoporosis is under-diagnosed and under-treated in the UK, with The National Osteoporosis Society estimating that by 2025, over 4 million people in the UK will have osteoporosis.

ICS was commissioned to develop an integrated osteoporosis service interfacing between primary and secondary care. The key driver was to identify and treat patients considered to be at risk of sustaining osteoporotic fractures.

Service Outcomes

  • Delivery of an active case finding service across 48 GP practices.
  • Identification of 2,545 patients deemed to be ‘at risk’ in year 1, with a further 674 patients identified in year 2.
  •  Identified ‘at risk’ patients treated according to agreed protocols, which reflected both national and local guidance.
  • 744 patients referred into the osteoporosis liaison service for DEXA confirmation of bone fracture risk.

The savings to the NHS are estimated to exceed £1 million and the improved prevention, detection and treatment of osteoporosis is forecast to prevent over 100 hip fractures within 4 years of project inception.

Fill in the form below to send ICS a message, and we will get back to you as soon as possible..


I would like to receive occasional updates about ICS.